Bellerophon Therapeutics Inc (BLPH)
0.0511
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Bellerophon Therapeutics Enterprise Value: -3.757M for April 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 22, 2024 | -3.757M |
| April 19, 2024 | -3.716M |
| April 18, 2024 | -3.684M |
| April 17, 2024 | -3.715M |
| April 16, 2024 | -3.715M |
| April 15, 2024 | -3.684M |
| April 12, 2024 | -3.709M |
| April 11, 2024 | -3.732M |
| April 10, 2024 | -3.648M |
| April 09, 2024 | -3.648M |
| April 08, 2024 | -3.737M |
| April 05, 2024 | -3.709M |
| April 04, 2024 | -3.719M |
| April 03, 2024 | -3.719M |
| April 02, 2024 | -3.732M |
| April 01, 2024 | -3.702M |
| March 28, 2024 | -3.687M |
| March 27, 2024 | -3.687M |
| March 26, 2024 | -3.676M |
| March 25, 2024 | -3.649M |
| March 22, 2024 | -3.709M |
| March 21, 2024 | -3.702M |
| March 20, 2024 | -3.757M |
| March 19, 2024 | -3.741M |
| March 18, 2024 | -3.686M |
| Date | Value |
|---|---|
| March 15, 2024 | -3.770M |
| March 14, 2024 | -3.648M |
| March 13, 2024 | -3.742M |
| March 12, 2024 | -3.729M |
| March 11, 2024 | -3.73M |
| March 08, 2024 | -3.723M |
| March 07, 2024 | -3.709M |
| March 06, 2024 | -3.737M |
| March 05, 2024 | -3.737M |
| March 04, 2024 | -3.752M |
| March 01, 2024 | -3.751M |
| February 29, 2024 | -3.752M |
| February 28, 2024 | -3.731M |
| February 27, 2024 | -3.743M |
| February 26, 2024 | -3.731M |
| February 23, 2024 | -3.745M |
| February 22, 2024 | -3.728M |
| February 21, 2024 | -3.728M |
| February 20, 2024 | -3.758M |
| February 16, 2024 | -3.710M |
| February 15, 2024 | -3.769M |
| February 14, 2024 | -3.769M |
| February 13, 2024 | -3.739M |
| February 12, 2024 | -3.758M |
| February 09, 2024 | -3.599M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.92M
Minimum
May 11 2022
132.64M
Maximum
May 22 2020
16.78M
Average
6.191M
Median
Jan 10 2022
Enterprise Value Benchmarks
| Janux Therapeutics Inc | 2.181B |
| NovaBay Pharmaceuticals Inc | 2.139M |
| Palatin Technologies Inc | 18.27M |
| iBio Inc | 16.07M |
| Theriva Biologics Inc | -13.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.921M |
| Total Expenses (Quarterly) | 2.17M |
| EPS Diluted (Quarterly) | -0.16 |
| Earnings Yield | -1.64K% |